Cargando…
Metabolomics Reveals Molecular Signatures for Psoriasis Biomarkers and Drug Targets Discovery
PURPOSE: Psoriasis is a chronic, multi-system skin disease that can be influenced by immunological, environmental, and genetic factors. Plasma metabolomic analysis can provide a great deal of information on potential diagnostic biomarkers, pathogenesis and personalized treatment. However, the role o...
Autores principales: | Song, Qian, Chen, Ying, Ma, JianQing, Zhou, Wei, Song, JunYan, Wu, ChunFu, Liu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631377/ https://www.ncbi.nlm.nih.gov/pubmed/37941849 http://dx.doi.org/10.2147/CCID.S433280 |
Ejemplares similares
-
Metabolomics and Biomarkers for Drug Discovery
por: Yeung, Pollen K.
Publicado: (2018) -
Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis
por: Chen, Chao, et al.
Publicado: (2021) -
Serum Metabolomic Profiling Reveals the Amelioration Effect of Methotrexate on Imiquimod-Induced Psoriasis in Mouse
por: Zong, Jiaxin, et al.
Publicado: (2020) -
Functional metabolomics: from biomarker discovery to metabolome reprogramming
por: Peng, Bo, et al.
Publicado: (2015) -
High-throughput metabolomics enables metabolite biomarkers and metabolic mechanism discovery of fish in response to alkalinity stress
por: Sun, Yan-chun, et al.
Publicado: (2018)